US2023159762A1PendingUtilityA1
Nir to swir fluorescent compounds for imaging and detection
Est. expirySep 29, 2037(~11.2 yrs left)· nominal 20-yr term from priority
C07D 409/08A61K 49/0058C07D 209/92C07D 209/90C07D 333/50A61P 35/00C07D 401/08C07D 403/08C09B 23/166A61K 49/0052A61K 51/0431C09B 1/005A61K 51/0497C07D 333/74C09B 1/002C07D 403/14G01N 33/582C09B 23/16A61K 51/0434A61K 51/0446
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure provides a family of compounds that absorb and fluoresce in the short wave infrared region (SWIR, optionally 1000 nm to 1300 nm), including hydrophilic compounds that exhibit absorption and emission spectral profiles in aqueous solutions substantially similar to those observed in organic solvents such as methanol or DMSO. The compounds can be chemically linked to biomolecules including proteins, nucleic acids, and therapeutic small molecules. The compounds are useful for imaging in a variety of medical, biological and diagnostic applications, including SWIR in vivo imaging of regions of interest within a mammal.
Claims
exact text as granted — not AI-modified1 . A compound represented by one of the following structures:
or a salt thereof, wherein:
R 1 is independently for each occurrence, hydrogen substituted or unsubstituted C 1 to C 24 alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic (e.g. morpholine) alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide, O, S, N, P, Si, C, (C═C), or L;
L is absent or is a linker moiety, optionally bearing a functional group or reactive group, wherein said functional group or reactive group is a carboxylate, carboxyalkyl, maleimide, succinimidyl ester, carboxamide, propargyl, azidoalkyl, alkyne, isothiocyanate, of —NH 2 —OH, —SH, —SO 3 H, carboxyl, —COCl, —CONHNH 2 , acetoxymethyl esters, substituted and unsubstituted N-hydroxysuccinimidyl esters, substituted and unsubstituted N-hydroxysulfosuccinimido esters, nitro- or fluoro or phenol esters, azide, —COCH 2 I, phosphoramidite, phthalamido, acyl fluoride, acyl chloride, acyl azide, tyramide, cinnamamide, hydroxycinnamamide, aldehyde, ketone, phosphoramidite, isocyanate, isothiocyanate, sulfonyl chloride, maleimide or biotin;
R 2 is a substituted or unsubstituted C 1 to C 24 alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, aryl sulfonate, C 1 to C 24 alkyl sulfonate, C 1 -C 24 alkyl carboxylate, aryl carboxylate, C 1 -C 24 alkylamine, arylamine, C 1 -C 24 alkylammonium, arylammonium, or substituted or unsubstituted polyethylene glycol.
2 . The compound of claim 1 , wherein R 2 is a substituted or unsubstituted C 1 to C 24 alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, aryl sulfonate, C 1 to C 24 alkyl sulfonate, C 1 -C 24 alkyl carboxylate, or aryl carboxylate.
3 . The compound of claim 1 , wherein R 1 is in each occurrence a sulfonate, alkyl sulfonate, arylsulfonate or taurine.
4 . The compound of claim 1 , wherein:
R 1 is in each occurrence a sulfonate, alkyl sulfonate, arylsulfonate or taurine; and R 2 is a substituted or unsubstituted C 1 to C 24 alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, aryl sulfonate, C 1 to C 24 alkyl sulfonate, C 1 -C 24 alkyl carboxylate, or aryl carboxylate.
5 . The compound of claim 4 , wherein R 1 in each occurrence is a sulfonate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.